Saturday, December 03, 2016
 
 
Video: Page (1) of 1 - 04/19/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Curis Inc Up 13% After Reporting Positive Clinical Results

By DMO Affiliate
Curis (NASDAQ:CRIS) is trading sharply higher today, after the company reported positive Phase II clinical results for its GDC-0449 treatment for advanced basel cell carcinoma, the most common form of skin cancer.The compound, from now on to be known as v
Curis Inc Up 13% After Reporting Positive Clinical Results




Page: 1


null
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines